🖤 Donations of all sizes power our public service journalism Give Now

Why do foreign countries pay less than the U.S. for prescription drugs?

Jul 9, 2019
The answer comes down to one key tactic: negotiation.
A pharmacy's green cross sign in Nantes, western France.

Another pharma megamerger: AbbVie buys Allergan for $63 billion

Jun 25, 2019
Both companies are under pressure to improve their performance.

Would requiring prices in pharmaceutical ads make drugs cheaper?

Apr 9, 2019
The idea is that transparency would lead to more competition and lower costs. One drug company is already on board.
Philippe Huguen/AFP/Getty Images

Walgreens has a tough quarter

Apr 2, 2019
Pharmacy chain Walgreens reported a 3.8 percent drop in sales for the quarter. The company cited a weak cough, cold and flu season — and declining profits from generic and branded prescription drugs. Click the audio player above to hear the full story.
People walk by a Walgreens store in San Francisco.
Justin Sullivan/Getty Images

Pharma executives in the hot seat over drug prices

Feb 26, 2019
Senior leaders of big pharmaceutical companies are in D.C. Tuesday to testify before a Senate committee.
jorgeantonio/iStock/Getty Images Plus

Big Pharma is betting big on cancer drugs

Jan 3, 2019
Bristol-Myers Squibb announced Thursday that it’s going to acquire another drugmaker, Celgene. The deal is worth about $74 billion. The combined company will have nine products with sales of more than a billion dollars a year, including some blockbuster cancer drugs. The merger is a sign that Big Pharma is betting big on cancer medications. […]

For public good, not for profit.

You can stop saying 'iconic' now

Jun 15, 2017
Humorist and language fussbudget Jenny Allen wants to squash these overused words and phrases.

Trump tells big pharma to cut their 'astronomical' drug prices

Feb 1, 2017
Will drug companies agree to the president's proposal?
 President Donald Trump meets with representatives from PhRMA, the Pharmaceutical Research and Manufacturers of America, on Tuesday.
Ron Sachs - Pool/Getty Images

New class of generics could save consumers, insurers billions. FDA is moving carefully.

Jul 13, 2016
The European Union has some 20 "biosimilar" generics on the market; the US has one.
Pre-filled syringes of  the adalimumab biosimilar.  The biosimilar is used in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis and ankylosing spondylitis.